Physician profile
Scott Pascal
NPI 1689069601
$11,818.47
in general payments reported to CMS, 2019-2025
10 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,341 · 2020: $1,117 · 2021: $2,987 · 2022: $2,843 · 2023: $1,694 · 2024: $1,182 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,553 · Food and Beverage: $979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,552.53 |
| Food and Beverage | $978.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,348.16 | 2019-2025 | T2, Pangea, T2 Alpha |
| Globus Medical, INC. | $4,331.63 | 2022-2025 | Ankle Fracture System, Anthem, Clavicular Fracture Fixation |
| Medical Device Business Services, INC. | $1,019.43 | 2019-2025 | Na, Attune |
| Depuy Synthes Sales INC. | $794.98 | 2019-2025 | Va-Lcp |
| Zimmer Biomet Holdings, INC. | $762.96 | 2021 | |
| Axogen | $300.89 | 2020-2021 | |
| Integra Lifesciences Corporation | $150.00 | 2020 | |
| Curvafix, INC. | $74.94 | 2023 | Curvafix Im Implant |
| Powerlink Ai, INC. | $18.73 | 2025 | |
| Bone Support INC. | $16.75 | 2025 | Ceramentbone Void Filler, Cerament G |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Pascal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.